Entero Healthcare Solutions Ltd.
ISIN: INE010601016 • Market Cap: ₹6,042 Cr
The 5-Pillar Quality Audit for Entero Healthcare Solutions Ltd.
Evaluated across Profitability, Financial Health, Historical Compounding, Valuation Safety, and Ownership Governance:
1. Profitability & Capital Efficiency
Weight: 25%Measures operating margins (4.4%), Return on Capital Employed (12.3%), and equity compounding (6.8%).
2. Financial Health & Solvency
Weight: 25%Debt-to-Equity is 0.34 with comfortable interest coverage and clean working capital.
3. Growth & Compounding Track Record
Weight: 20%Historical 3Y Sales CAGR (22.0%) and 3Y PAT CAGR (62.5%).
4. Valuation Multiple & Margin of Safety
Weight: 15%Trades at P/E of 48.18 vs PEG of 1.70 and Dividend Yield of —.
5. Ownership Quality & Governance
Weight: 15%Promoter holding stands at 52.4%, backed by 19.9% institutional ownership.
Key Fundamental Strengths
Strong Topline Expansion (3Y Sales CAGR: 22.0%)
Revenue has expanded at 22.0% CAGR over 3 years, signaling industry market-share gains.
High-Velocity Profit Compounding (3Y PAT CAGR: 62.5%)
Net earnings have compounded at 62.5% annualized, demonstrating operating leverage.
Areas to Watch & Potential Risks
Sectoral & Macro Headwinds (Consumer Services)
Subject to broader cyclical demand, raw material price shifts, and regulatory frameworks governing the Consumer Services space.
Quantitative Strategy Eligibility
Checking ENTERO against established Indian wealth creation frameworks:
Coffee Can Investing Framework
Fails 10%+ revenue growth or 15%+ minimum capital return benchmark over historical periods.
Quality Factor Screener (High RoIC + Low Debt)
Scorecard of 69/100 or leverage profile sits below strict quality index hurdles.
GARP / Value-Growth Blend
Valuation multiple or return metrics require further cyclical pullback.
Consumer Services Sector Peer Comparison
Compare ENTERO directly against top industry peers by market capitalization:
| Company | 5-Pillar Score | Market Cap | P/E | ROCE | D/E | Scorecard |
|---|---|---|---|---|---|---|
| Entero Healthcare Solutions Ltd. (ENTERO)Current | 69/100 | ₹6,042 Cr | 48.18 | 12.3% | 0.34 | — |
| Eternal Ltd. (ETERNAL) | 61/100 | ₹3.09 Lakh Cr | 713.64 | 2.9% | 0.00 | View |
| Avenue Supermarts Ltd. (DMART) | 66/100 | ₹2.60 Lakh Cr | 84.88 | 16.4% | 0.04 | View |
| Trent Ltd. (TRENT) | 74/100 | ₹1.57 Lakh Cr | 86.78 | 29.6% | 0.07 | View |
| Lenskart Solutions Ltd. (LENSKART) | 63/100 | ₹1.11 Lakh Cr | 169.67 | 8.4% | 0.03 | View |
| Indian Hotels Co. Ltd. (INDHOTEL) | 75/100 | ₹1.03 Lakh Cr | 48.02 | 16.0% | 0.00 | View |
Frequently Asked Questions: Entero Healthcare Solutions Ltd.
Q:What is the 5-Pillar Fundamental Score for Entero Healthcare Solutions Ltd. (ENTERO)?
Entero Healthcare Solutions Ltd. has a RupeeTools Fundamental Score of 69/100, placing it in the 'Solid & Healthy' category. Its pillar scores are: Profitability (43/100), Financial Health (80/100), Growth (92/100), Valuation (52/100), and Ownership Quality (78/100).
Q:Is ENTERO fundamentally strong for long-term investment?
ENTERO currently holds a moderate quality rating of 69/100. While it operates in the Consumer Services sector, investors should monitor its profit margins before initiating long-term positions.
Q:Does ENTERO pass the Coffee Can Investing filter?
No. ENTERO does not currently meet the strict 15% ROCE and 10% sustained topline compounding threshold mandated by the Coffee Can investing framework.
Q:How does ENTERO compare against other Consumer Services peers?
Within India's Consumer Services sector, ENTERO trades at a P/E of 48.18 and generates an ROCE of 12.3%. Compare its 5-Pillar score of 69/100 against top sector peers like Eternal Ltd. (61/100), Avenue Supermarts Ltd. (66/100).
Regulatory & SEBI Research Analyst Compliance Disclaimer:
This 5-pillar fundamental score is an automated quantitative health check generated purely from historical public financial statements, corporate filings, and exchange disclosures for educational and informational purposes only. It does NOT constitute investment advice, a stock recommendation, or a solicitation to buy or sell securities. RupeeTools is not a SEBI-registered Research Analyst. Please consult a SEBI-registered financial advisor before making investment decisions.